Formation spécialisée sur le cancer de la prostate

Formation spécialisée sur le cancer de la prostate
-
Hors HUG
Symposium
Evénement professionnel

Cette formation a pour but le partage d’expériences sur le traitement du cancer de la prostate entre deux pays et deux cultures différentes.

Informations pratiques

  • Mercredi 16 décembre 2026 de 9h à 16h15 et jeudi 17 décembre 2026 de 9h à 16h
  • SWISS Foundation for Innovation and Training in Surgery (SFITS), Rue Gabrielle-Perret-Gentil 4, 1205 Geneva
  • Conférence en anglais
  • Sur inscription à l'adresse suivante : Catherine.Cretton@hug.ch

Programme

Module 1 - Mercredi 16 décembre

09:00-10:15 : part 1
Moderators: Dr Bülent Karabulut, President of TTOD, medical oncologist of Acibadem Kent and Pr Alfredo Addeo, M.D., head of Medical oncology division, HUG

  • 09:00-09:15 Opening session
    Dr. Bülent Karabulut
    Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG
  • 09:15-09:45 The role of active surveillance
    Dr D. Benamran, staff physician, Urology division, HUG
  • 09:45-10:15 PET PSMA in prostate cancer
    Pre Valentina Garibotto, M.D., head of Nuclear medicine division, HUG
  • 10:15-10:30 Coffee Break

10:30-12:00 :part 2
Moderators : Pr. Dr. Mustafa Erman, Medical oncologist at Hacettepe University Hospital and Dr D. Benamran, Urology division, HUG

  • 10:30-11:00 Prostatectomy in localized prostate cancer
    Pr Massimo Valerio, M.D., head of Urology division and Prostate centre, HUG
  • 11:00-11:30 Radiotherapy in localized prostate cancer
    Pr M. Shelan, Radiation oncologist, Bern
  • 11:30-12:00 New paradigms and future directions in metastatic prostate cancer treatment
    Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG
  • 12:00-13:00 Lunch Break

13:00-14:30 : part 3
Moderator: Pr Dr Deniz Tural, Medical oncologist at Koç University Hospital

  • 13:00-13:30 The role of RMN in localized and metastatic prostate cancer
    Dr Thomas De Perrot,  radiologist, Prostate centre, HUG
  • 13:00-14:30
    • mHSPC Low volume: multidisciplinary approach
      Dr Dominik Berthold, oncologist, head of Prostate ceentre, CHUV
    • mHSPC – High volume: Defining the standard of care
      Dr Emre Yekedüz, Medical oncologist at Ankara University Hospital
  • 14:30-14:45 Coffee Break

14:45-16:15 : part 4
Moderator: Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG and Dr Gökşen İnanç İmamoğlu, Medical oncologist at Ankara City Hospital

  • 14:45-15:15 ARPIs in prostate cancer: patient selection and personalized treatment 
    Dr Gökşen İnanç İmamoğlu, Medical oncologist at Ankara City Hospital
  • 15:15-16:15 Clinical scenarios and discussion 
    Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG
     

Module 2 – jeudi 17 décembre

09:00-10:30 : part 1
Moderator: Dr Mustafa Erman, Medical oncologist at Hacettepe University Hospital

  • 09:00-09:30 Radioligand therapy in prostate cancer: new standards & future directions 
    Dr Nicola Bianchetto M.D., Senior Resident, Nuclear medicine division, HUG)
  • 09:30-10:00 Castration-Resistant Prostate Cancer: Sequencing and Precision Treatment 
    Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG
  • 10:00-10:30 RECIST and PCWG3 – clinical practice and trials 
    Dr Mustafa Erman, Medical oncologist at Hacettepe University Hospital
  • 10:30-10:45 Coffee Break

10:45-12:00 : part 2
Moderator: Dr Bülent Karabulut, President ot TTOD, Medical oncologist of Acibadem Kent Hospital

  • 10:45-12:00 Clinical scenarios and discussion 
    Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG
  • 12:00-13:00 Lunch Break
  • 13:00-16:00 TTOD Session-Insights and Reflections on Preceptorship 
    Moderator: Pr Dr Bülent Karabulut, 
    Speakers: Dr Mustafa Erman, Dr Deniz Tural, Dr Gökşen İnanç İmamoğlu, Dr Emre Yekedüz
     

Inscription

Places limitées.

Pour vous inscrire, merci d'adresser un email à :

Photo
Image
Catherine Cretton
Catherine Cretton
Assistante du Pr Alfredo Addeo
Téléphone
Dernière mise à jour : 12/11/2026